Ranibizumab ophthalmic and Zofran ODT Oral, Oromucosal
Determining the interaction of Ranibizumab ophthalmic and Zofran ODT Oral, Oromucosal and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
Generic Name: ondansetron
Brand name: Zofran, Zofran ODT, Zuplenz
Synonyms: Zofran ODT
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ranibizumab ophthalmic-Zofran Oral, Oromucosal
- Ranibizumab ophthalmic-Zohydro ER
- Ranibizumab ophthalmic-Zohydro ER Capsules
- Ranibizumab ophthalmic-Zoladex
- Ranibizumab ophthalmic-Zoladex (Goserelin Implant 10.8 mg)
- Ranibizumab ophthalmic-Zoladex (Goserelin Implant 3.6 mg)
- Zofran ODT Oral, Oromucosal-Ranitidine
- Zofran ODT Oral, Oromucosal-Ranitidine Capsule
- Zofran ODT Oral, Oromucosal-Ranitidine Hydrochloride
- Zofran ODT Oral, Oromucosal-Ranitidine Injection
- Zofran ODT Oral, Oromucosal-Ranitidine Suspension
- Zofran ODT Oral, Oromucosal-Ranitidine Syrup